Nebulized Lipopolysaccharide Causes Delayed Cortical Neuroinflammation in a Murine Model of Acute Lung Injury
International Journal of Molecular Sciences · 20.09.2024 · 25 (18) · 10117
DOI: 10.3390/ijms251810117 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.09.2024. Verfasst von Katharina Ritter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University Medical Center of the Johannes-Gutenberg-University, Langenbeckstrasse 1, 55131 Mainz, Germany. Hauptthemen laut MEDLINE: Lipopolysaccharides, Disease Models, Animal, Acute Lung Injury, Mice, Inbred C57BL. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung injury caused by respiratory infection is a major cause of hospitalization and mortality and a leading origin of sepsis. Sepsis-associated encephalopathy and delirium are frequent complications in patients with severe lung injury, yet the pathogenetic mechanisms remain unclear. Here, 70 female C57BL/6 mice were subjected to a single full-body-exposure with nebulized lipopolysaccharide (LPS). Neuromotor impairment was assessed repeatedly and brain, blood, and lung samples were analyzed at survival points of 24 h, 48 h, 72 h, and 96 h after exposure. qRT-PCR revealed increased mRNA-expression of TNFα and IL-1β 24 h and 48 h after LPS-exposure in the lung, concomitantly with increased amounts of proteins in bronchoalveolar lavage and interstitial lung edema. In the cerebral cortex, at 72 h and/or 96 h after LPS exposure, the inflammation- and activity-associated markers TLR4, GFAP, Gadd45b, c-Fos, and Arc were increased. Therefore, single exposure to nebulized LPS not only triggers an early inflammatory reaction in the lung but also induces a delayed neuroinflammatory response. The identified mechanisms provide new insights into the pathogenesis of sepsis-associated encephalopathy and might serve as targets for future therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, University Medical Center of the Johannes-Gutenberg-University, Langenbeckstrasse 1, 55131 Mainz, Germany.
- Research Center for Immunotherapy (FZI), Johannes-Gutenberg-University, 55131 Mainz, Germany.
- Focus Program Translational Neurosciences (FTN), Johannes-Gutenberg-University, 55131 Mainz, Germany.
ORCID-Profile: Michael K E Schäfer
Zitieren
APA
Ritter, K., Rissel, R., Renz, M., Ziebart, A., Schäfer, M. K. E., & Kamuf, J. (2024). Nebulized Lipopolysaccharide Causes Delayed Cortical Neuroinflammation in a Murine Model of Acute Lung Injury. International Journal of Molecular Sciences, 25(18), 10117. https://doi.org/10.3390/ijms251810117
Vancouver
Ritter K, Rissel R, Renz M, Ziebart A, Schäfer MKE, Kamuf J. Nebulized Lipopolysaccharide Causes Delayed Cortical Neuroinflammation in a Murine Model of Acute Lung Injury. International Journal of Molecular Sciences. 2024;25(18):10117. doi:10.3390/ijms251810117
BibTeX
@article{Ritter2024,
author = {Ritter, Katharina and Rissel, René and Renz, Miriam and Ziebart, Alexander and Schäfer, Michael K E and Kamuf, Jens},
title = {Nebulized Lipopolysaccharide Causes Delayed Cortical Neuroinflammation in a Murine Model of Acute Lung Injury},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {18},
pages = {10117},
doi = {10.3390/ijms251810117}
}
EUVIMED